{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:32:32Z","timestamp":1767166352645,"version":"build-2238731810"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Waldenstrom macroglobulinaemia (WM) is an incurable lymphoplasmacytic lymphoma with secretion of serum monoclonal immunoglobulin M (IgM). We previously showed that patients receiving cholesterol\u2010lowering statins, had the lowest IgM value in a large cohort of patients with WM. Simvastatin, a 3\u2010hydroxy\u20103\u2010methyl\u2010glutaryl\u2010CoA reductase inhibitor, induced inhibition of proliferation, cytotoxic effect and apoptosis in IgM secreting cell lines as well as in primary CD19\n                    <jats:sup>+<\/jats:sup>\n                    WM cells. Interestingly, those effects were reversed by addition of mevalonate and geranylgeranylpyrophosphate, demonstrating that simvastatin inhibited cell growth, survival and IgM secretion on BCWM.1 WM cells by inhibition of geranylgeranylated proteins. Furthermore, simvastatin overcame tumour cell growth induced by co\u2010culture of WM cells with bone\u2010marrow stromal cells. Simvastatin also decreased IgM secretion by BCWM.1 cells at an early time\u2010point that had not affected cell survival. Simvastatin\u2010induced cytotoxicity was preceded by a decrease in Akt (protein kinase B, PKB) and extracellular signal\u2010regulated kinase (ERK) mitogen\u2010activated protein kinase (MAPK) pathways at 18\u2003h. In addition, simvastatin induced an increase in stress\u2010activated protein kinase\/c\u2010Jun N\u2010terminal kinase (SAPK\/JNK) MAPK followed by caspase\u20108, \u20109, \u20103 and poly(ADP\u2010ribose) polymerase (PARP) cleavages at 18\u2003h, leading to apoptosis. Furthermore, simvastatin enhanced the cytotoxicity induced by bortezomib, fludarabine and dexamethasone. Our studies therefore support our earlier observation of statin\u2010mediated anti\u2010WM activity and provide the framework for future clinical trials testing simvastatin in WM.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07257.x","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T06:38:57Z","timestamp":1212647937000},"page":"775-785","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The HMG\u2010CoA inhibitor, simvastatin, triggers\n                    <i>in vitro<\/i>\n                    anti\u2010tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia"],"prefix":"10.1111","volume":"142","author":[{"given":"Anne\u2010Sophie","family":"Moreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Soumerai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai T.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evdoxia","family":"Hatjiharissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary R.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2507"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50043"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.8659"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005488"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(02)00124-9"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.080517697"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402501"},{"key":"e_1_2_6_9_1","first-page":"5735","article-title":"Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells","volume":"9","author":"Van De Donk N.W.","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/1078-0432.429.11.2","article-title":"Geranylgeranylated proteins are involved in the regulation of myeloma cell growth","volume":"11","author":"Van De Donk N.W.","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3552"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.21.6426"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.00152.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.2943"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200360200"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3434"},{"key":"e_1_2_6_17_1","first-page":"1149","article-title":"Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin","volume":"24","author":"Kozar K.","year":"2004","journal-title":"International Journal of Oncology"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.651"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.2.753"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054577"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.08.053"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1056"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50082"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"270b","DOI":"10.1182\/blood.V108.11.4749.4749","article-title":"Abnormalities in lipoprotein metabolism provide insight into novel therapeutic approaches for Waldenstrom\u2019s macroglobulinemia","volume":"108","author":"Patterson C.J.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.22.13283"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0352"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.029"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(97)00120-4"},{"key":"e_1_2_6_29_1","first-page":"542","article-title":"Dose\u2010finding study of high\u2010dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma","volume":"91","author":"Van Der Spek E.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4477"},{"key":"e_1_2_6_31_1","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault A.","year":"1996","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1112"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0833"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-055012"}],"updated-by":[{"DOI":"10.1111\/bjh.19479","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000}}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07257.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T23:48:06Z","timestamp":1695944886000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07257.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07257.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07257.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"2008-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}